Skip to main content
Top
Published in: Diabetologia 4/2008

01-04-2008 | Letter

Expanding human beta cells

Author: R. Scharfmann

Published in: Diabetologia | Issue 4/2008

Login to get access

Excerpt

To the Editor: An understanding of how beta cell number is regulated during normal life and regeneration is crucial not only from a cognitive point of view, but also forms a basis for the development of new strategies to treat or cure diabetic patients. Beta cell homeostasis is the balance between beta cell formation and death. Beta cells can be formed by neogenesis from non-beta cells (differentiation from progenitors, transdifferentiation from exocrine cells) or by the proliferation of beta cells already present in the pancreas. For a long time, it was thought that the rate of beta cell proliferation was extremely low and played a minor role in beta cell expansion occurring during adult life. This hypothesis was convincingly challenged by lineage-based approaches demonstrating that, during physiological adult life, newly formed beta cells are derived from pre-existing beta cells [1]. This important finding led to a large number of teams entering the field of beta cell proliferation, which produced major new information and a better understanding of this important topic [2]. It is thus now proposed that strategies that would enhance beta cell proliferation can be used to develop human endocrine cells in large quantities to be used for diabetes therapy in humans. However, it should be kept in mind that the vast majority of the recent data on beta cell proliferation are derived from rodent models. Thus, in my view, a major question is: is the recent information demonstrating the major role of beta cell proliferation in the rodent true for human beta cells? …
Literature
1.
go back to reference Dor Y, Brown J, Martinez OI, Melton DA (2004) Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41–46PubMedCrossRef Dor Y, Brown J, Martinez OI, Melton DA (2004) Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41–46PubMedCrossRef
2.
go back to reference Karnik SK, Chen H, McLean GW et al (2007) Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science 318:806–809PubMedCrossRef Karnik SK, Chen H, McLean GW et al (2007) Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science 318:806–809PubMedCrossRef
3.
go back to reference Eizirik D, Pipeleers D, Ling Z, Welsh N, Hellerstrom C, Andersson A (1994) Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury. Proc Natl Acad Sci U S A 91:9253–9256PubMedCrossRef Eizirik D, Pipeleers D, Ling Z, Welsh N, Hellerstrom C, Andersson A (1994) Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury. Proc Natl Acad Sci U S A 91:9253–9256PubMedCrossRef
4.
go back to reference DeVos A, Heimberg H, Quartier E et al (1995) Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 96:2489–2495CrossRef DeVos A, Heimberg H, Quartier E et al (1995) Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 96:2489–2495CrossRef
5.
go back to reference Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A (2006) The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 103:2334–2339PubMedCrossRef Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A (2006) The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 103:2334–2339PubMedCrossRef
6.
go back to reference Hayek A, Beattie GM, Cirulli V, Lopez AD, Ricordi C, Rubin JS (1995) Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes 44:1458–1460PubMedCrossRef Hayek A, Beattie GM, Cirulli V, Lopez AD, Ricordi C, Rubin JS (1995) Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes 44:1458–1460PubMedCrossRef
7.
go back to reference Lefebvre VH, Otonkoski T, Ustinov J, Huotari MA, Pipeleers DG, Bouwens L (1998) Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for beta-cells. Diabetes 47:134–137PubMedCrossRef Lefebvre VH, Otonkoski T, Ustinov J, Huotari MA, Pipeleers DG, Bouwens L (1998) Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for beta-cells. Diabetes 47:134–137PubMedCrossRef
8.
go back to reference Parnaud G, Bosco D, Berney T et al (2008) Proliferation of sorted human and rat beta cells. Diabetologia 51:91–100PubMedCrossRef Parnaud G, Bosco D, Berney T et al (2008) Proliferation of sorted human and rat beta cells. Diabetologia 51:91–100PubMedCrossRef
9.
10.
go back to reference Teta M, Long SY, Wartschow LM, Rankin MM, Kushner JA (2005) Very slow turnover of beta-cells in aged adult mice. Diabetes 54:2557–2567PubMedCrossRef Teta M, Long SY, Wartschow LM, Rankin MM, Kushner JA (2005) Very slow turnover of beta-cells in aged adult mice. Diabetes 54:2557–2567PubMedCrossRef
Metadata
Title
Expanding human beta cells
Author
R. Scharfmann
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0909-4

Other articles of this Issue 4/2008

Diabetologia 4/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine